Uttam Sugar Mills Limited (BOM:532729)

Market Cap	9.89B
Revenue (ttm)	18.46B
Net Income (ttm)	883.10M
Shares Out	38.14M
EPS (ttm)	23.16
PE Ratio	11.20
Forward PE	n/a
Dividend	2.50 (0.96%)
Ex-Dividend Date	Sep 11, 2024

Volume	7,664
Average Volume	2,131
Open	261.60
Previous Close	261.50
Day's Range	255.00 - 268.20
52-Week Range	170.05 - 395.90
Beta	0.60
RSI	27.68
Earnings Date	May 30, 2025

About Verve Therapeutics

Uttam Sugar Mills Limited manufactures and sells sugar products under the Uttam brand in India and internationally. It operates through Sugar, Cogeneration, and Distillery segments. The company offers pharma, double refined, planation white, and demerara sugar, as well as invert sugar syrup; and liquid, natural brown, sulphur free and bura, icing, superfine, mishri candi, white sachet, brown, table, brown and white cube, and caster sugar. It also provides industrial alcohol and ethanol; and engages in power generation business. In addition, the...

• Industry: Sugar And Confectionery Products
• Founded: 1960
• Employees: 852
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532729

Financial Performance

In 2024, Uttam Sugar Mills's revenue was 18.46 billion, a decrease of -9.82% compared to the previous year's 20.47 billion. Earnings were 883.10 million, a decrease of -33.20%.